Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
TENET HEALTHCARE CORP incurred revolving credit of up to $1.9 billion with JPMorgan Chase Bank, N.A., as administrative agent at Term SOFR, Daily Simply SOFR or EURIBOR Rate plus an applicable margin ranging f maturing November 4, 2030.
- Instrument
- revolving credit
- Principal
- up to $1.9 billion
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent
- Rate
- Term SOFR, Daily Simply SOFR or EURIBOR Rate plus an applicable margin ranging f
- Maturity
- November 4, 2030
- Event
- incurrence
Exact text from the filing
The ABL Agreement has an effective date of November 4, 2025 and provides for, subject to borrowing availability, revolving loans in an aggregate principal amount of up to $1.9 billion with a $200 million sub-facility for letters of credit. Tenet’s borrowing availability under the ABL Agreement is calculated by reference to a borrowing base which is determined
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
TENET HEALTHCARE CORP amended credit facility of up to $200 million with Barclays Bank PLC, as administrative agent at base rate plus a margin equal to 0.25% per annum maturing November 4, 2030.
- Instrument
- credit facility
- Principal
- up to $200 million
- Counterparty
- Barclays Bank PLC, as administrative agent
- Rate
- base rate plus a margin equal to 0.25% per annum
- Maturity
- November 4, 2030
- Event
- amendment
Exact text from the filing
has an effective date of November 4, 2025 and provides for, subject to borrowing availability, revolving loans in an aggregate principal amount of up to $1.9 billion with a $200 million sub-facility for letters of credit. Tenet’s borrowing availability under the ABL Agreement is calculated by reference to a borrowing base which is determined by specified
View on SEC.gov